Medical devices, healthcare technology and the business of care
COMPANY INTELLIGENCE

Neuros Medical, Inc.

Explore this company’s associated devices, FDA decisions and regulatory history.

Clinical monitoring equipment, editorial photography

Neuros Medical, Inc.

Regulatory records
5
Linked recall entries
0
Headquarters
Not reported
Brand website
Not reported
COMPANY INTELLIGENCE

What the linked records show

MedtechLedger currently links 5 FDA records to the applicant name Neuros Medical, Inc.. It includes 1 original PMA approval. 2 entries are PMA supplements. 2 entries are 30-day notices. These are records held by this publication, rather than a count of the company’s entire portfolio.

The dated entries run from Aug 26, 2024 to Oct 16, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.

Product code SAZ appears in 5 of the 5 linked filings. The collection spans 1 FDA product code and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.

The largest PMA family in this collection is P230020, with 5 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes. 1 linked filing has a current plain-language explanation checked against the recorded FDA decision.

Applicant mailing address recorded by FDA: 26800 Aliso Viejo Pkwy., Suite 250, Aliso Viejo, CA, 92656. Recorded on P230020/S011, decision dated Oct 16, 2026.

Changes described in PMA records

P230020/S011: Altius Direct Electrical Nerve Stimulation System

The FDA record P230020/S011 shows a 30-day notice, decision OK30 dated 2026-10-16, for the Altius® Direct Electrical Nerve Stimulation System from Neuros Medical, Inc. The stated change is outsourcing insulator die-cutting activities and updating the associated dimensional tolerances. The supplement reason is filed as a process change affecting manufacturer, sterilizer, packager or supplier. This is a manufacturing supplement to PMA P230020, not a new approval of the whole system.

The supplied statement does not specify which die-cutting steps move to which supplier, what tolerance values changed, or what verification the applicant submitted. Its reported purpose is a process change; the notice itself does not demonstrate safety or clinical effectiveness, and no new indication or trial is implied. The device category field covers a totally implanted nerve terminus stimulator for chronic intractable post-amputation pain of the lower limb, product code SAZ.

FDA approval-order wording

outsourcing insulator die-cutting activities and updating the associated dimensional tolerances

Oct 16, 2026 · 30-Day Notice

P230020/S006: Altius Direct Electrical Nerve Stimulation System

FDA’s recorded scope: approval for the addition of an alternate test method (Bacterial Endotoxin Testing Chromogenic) for endotoxin testing of the Implantable Pulse Generator (IPG) and IPG Accessory Kit components of the Altius System and a change in the test lab supplier for endotoxin testing from Integer Uruguay to Labcorp and Integer Plymouth.

May 5, 2026 · 135 Review Track For 30-Day Notice

P230020/S005: Altius Direct Electrical Nerve Stimulation System

FDA’s recorded scope: approval for a manufacturing site located at Neuros Medical, Inc., 1212 Red Fox Road, Arden Hills, Minnesota, 55112. The main manufacturing operations performed at this facility include, but are not limited to, the receipt of sterile and non-sterile finished packaged devices ready for distribution from two contract manufacturing organization facilities, evaluation of returned devices, calibration and maintenance of inspection equipment, and serve as the specification developer and design control center.

Dec 3, 2025 · Normal 180 Day Track No User Fee

P230020: Altius Direct Electrical Nerve Stimulation System

FDA’s recorded scope: Approval order for Altius Direct Electrical Nerve Stimulation System. This device is indicated as an aid in the management of chronic intractable phantom and residual lower limb post-amputation pain in adult amputees.

Aug 26, 2024

Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.

Regulatory record history

  1. Altius Direct Electrical Nerve Stimulation System

    P230020/S011 · PMA supplement
  2. Altius Direct Electrical Nerve Stimulation System

    P230020/S006 · PMA supplement
  3. Altius Direct Electrical Nerve Stimulation System

    P230020/S007 · PMA supplement
  4. Altius Direct Electrical Nerve Stimulation System

    P230020/S005 · PMA supplement
  5. Altius Direct Electrical Nerve Stimulation System

    P230020 · PMA decision
Source information

Source updated Nov 9, 2026. Retrieved Nov 21, 2026.